Literature DB >> 26475518

Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT(2A) receptor.

Shashikanth Ponnala1, Nirav Kapadia2, Sudharshan Madapa1, Ian L Alberts3, Wayne W Harding4.   

Abstract

A series of C1 aporphine analogs related to compound 5 and that contain substituted allylic, alkynyl, nitrile, ester and benzyl groups was synthesized and evaluated for affinity at h5HT2A and α1A receptors in functional activity assays that measure calcium release. The presence of branched allylic substituent groups diminished affinity for the h5HT2A receptor. Likewise, the alkynyl, nitrile and ester derivatives evaluated displayed lower 5-HT2A receptor affinity as compared to 5. Hydrophobic, steric and electronic effects impact the affinity of p-substituted benzyl derivatives 8i-8k but in different ways. High hydrophobicity and size favor 5-HT2A affinity whereas, high electronegativity disfavors 5-HT2A affinity. p-Bromobenzyl analog 8k was identified as a 5-HT2A receptor selective ligand, with the highest 5-HT2A receptor affinity of any aporphine known to date. Most of the other analogs were selective for the 5-HT2A versus the α1A receptor. ChemScore binding energies from docking studies correlated qualitatively with the observed trends in affinity for 8i-8k, although the binding energies were not well differentiated quantitatively.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5-HT(2A); Adrenergic; Antagonist; Aporphine; Nantenine

Mesh:

Substances:

Year:  2015        PMID: 26475518      PMCID: PMC4628873          DOI: 10.1016/j.bmcl.2015.10.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

Review 1.  Advances in development of dopaminergic aporphinoids.

Authors:  Ao Zhang; Yi Zhang; Alan R Branfman; Ross J Baldessarini; John L Neumeyer
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

2.  Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.

Authors:  Stevan Pecic; Pooja Makkar; Sandeep Chaudhary; Boojala V Reddy; Hernan A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem       Date:  2010-06-20       Impact factor: 3.641

3.  Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.

Authors:  Shashikanth Ponnala; Junior Gonzales; Nirav Kapadia; Hernan A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2014-03-04       Impact factor: 2.823

4.  (6aR)-11-amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease.

Authors:  Rui Zhao; Weijian Lu; Xing Fang; Lin Guo; Zhi Yang; Na Ye; Jiahao Zhao; Zhili Liu; Jia Jia; Longtai Zheng; Bin Zhao; Ao Zhang; Xuechu Zhen
Journal:  Pharmacol Biochem Behav       Date:  2014-06-21       Impact factor: 3.533

5.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.

Authors:  J M Baldwin; G F Schertler; V M Unger
Journal:  J Mol Biol       Date:  1997-09-12       Impact factor: 5.469

6.  New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.

Authors:  Sandeep Chaudhary; Shashikanth Ponnala; Onica Legendre; Junior A Gonzales; Hernán A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem       Date:  2011-08-18       Impact factor: 3.641

7.  Microwave-Assisted Direct Biaryl Coupling: First Application to the Synthesis of Aporphines.

Authors:  Sandeep Chaudhary; Stevan Pecic; Onica Legendre; Wayne W Harding
Journal:  Tetrahedron Lett       Date:  2009-05-20       Impact factor: 2.415

8.  Structure-based identification of aporphines with selective 5-HT(2A) receptor-binding activity.

Authors:  Vani Munusamy; Beow Keat Yap; Michael J C Buckle; Stephen W Doughty; Lip Yong Chung
Journal:  Chem Biol Drug Des       Date:  2012-11-14       Impact factor: 2.817

9.  5-HT(2A) inverse-agonists for the treatment of insomnia.

Authors:  Bradley R Teegarden; Hussien Al Shamma; Yifeng Xiong
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

Review 10.  New perspectives for the treatment of disorders of sleep and arousal.

Authors:  D J Sanger; C Soubrane; B Scatton
Journal:  Ann Pharm Fr       Date:  2007-07
View more
  3 in total

1.  Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity.

Authors:  Anupam Karki; Reecan Juarez; Hari K Namballa; Ian Alberts; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2020-02-20       Impact factor: 2.823

2.  Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists.

Authors:  Hui Li Heng; Chin Fei Chee; Sek Peng Chin; Yifan Ouyang; Hao Wang; Michael J C Buckle; Deron R Herr; Ian C Paterson; Stephen W Doughty; Noorsaadah Abd Rahman; Lip Yong Chung
Journal:  Medchemcomm       Date:  2018-02-26       Impact factor: 3.597

3.  Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist.

Authors:  John D Chan; Sreemoyee Acharya; Timothy A Day; Jonathan S Marchant
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-06-23       Impact factor: 4.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.